beta

APEN

Apollo Endosurgery Inc.

Apen

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-08-2018 after market close 08-08-2018 after market close 05-03-2018 after market close 03-01-2018 after market close 10-26-2017 after market close 08-01-2017 after market close
Actual EPS -0.45 -0.53 -0.47 -0.42 -0.32 -0.64
Consensus EPS -0.34 -0.43 -0.4 -0.34 -0.39
Estimated EPS -0.34 -0.43 -0.4 -0.34 -0.39
Number of Estimates 3 3 3 3 2
EPS Surprise -$0.11 -$0.10 -$0.07 -$0.08 $0.07

Stats

Summary

Apollo Endosurgery Inc is a developer of medical devices in the United States. The company's major focus area is obesity and gastrointestinal diseases.

Market Cap: 107 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.apolloendo.com

Shares Outstanding: 17.3 Million

Float: 15.6 Million

Dividend: 0.0 (0.0%)

Beta: 0.600909

Sector: Healthcare

Industry: Medical Devices

Short Interest (Jan 12, 2018): 197 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1414 trading days

From: 2013-07-31 To: 2018-12-11

Lowest Point:

Apollo Endosurgery Announces First Commercial Shipment of the OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-11-27 16:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the first commercial shipments of the OverStitch Sx Endoscopic Suturing System. These initial customer ship… read more...

Apollo Endosurgery Announces First Commercial Shipment of the OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-11-27 16:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the first commercial shipments of the OverStitch Sx Endoscopic Suturing System. These initial customer ship… read more...

Apollo Endosurgery Announces First Commercial Shipment of the OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-11-27 16:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the first commercial shipments of the OverStitch Sx Endoscopic Suturing System. These initial customer ship… read more...

Apollo Endosurgery Features Industry-Leading Endoscopic Procedure Portfolio at Obesity Week 2018 Conference

via: Business Wire at 2018-11-12 18:46:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced its participation during Obesity Week 2018 taking place November 11-15, 2018 at The Music City Center in Nashville, Tennes… read more...

Apollo Endosurgery Features Industry-Leading Endoscopic Procedure Portfolio at Obesity Week 2018 Conference

via: Business Wire at 2018-11-12 18:46:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced its participation during Obesity Week 2018 taking place November 11-15, 2018 at The Music City Center in Nashville, Tennes… read more...

Apollo Endosurgery Features Industry-Leading Endoscopic Procedure Portfolio at Obesity Week 2018 Conference

via: Business Wire at 2018-11-12 18:46:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced its participation during Obesity Week 2018 taking place November 11-15, 2018 at The Music City Center in Nashville, Tennes… read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-10 16:49:05:000

Apollo Endosurgery, Inc. (APEN) Q3 2018 Earnings Conference Call November 8, 2018 4:30 PM ET Executives John Gillings Investor Relations Todd Newton Chief Executive Officer Stefanie Cavanaugh Chief Financial Officer Analysts Matt Hewitt … read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-10 16:49:05:000

Apollo Endosurgery, Inc. (APEN) Q3 2018 Earnings Conference Call November 8, 2018 4:30 PM ET Executives John Gillings Investor Relations Todd Newton Chief Executive Officer Stefanie Cavanaugh Chief Financial Officer Analysts Matt Hewitt … read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-10 16:49:05:000

Apollo Endosurgery, Inc. (APEN) Q3 2018 Earnings Conference Call November 8, 2018 4:30 PM ET Executives John Gillings Investor Relations Todd Newton Chief Executive Officer Stefanie Cavanaugh Chief Financial Officer Analysts Matt Hewitt … read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-10 16:49:05:000

Apollo Endosurgery, Inc. (APEN) Q3 2018 Earnings Conference Call November 8, 2018 4:30 PM ET Executives John Gillings Investor Relations Todd Newton Chief Executive Officer Stefanie Cavanaugh Chief Financial Officer Analysts Matt Hewitt … read more...

Microcaps tops list of midday movers

via: SeekingAlpha at 2018-11-09 12:43:17:000

More news on: Novelion Therapeutics, Inc., RETO Eco-Solutions, Pro-Dex, Inc., Stocks on the move, , Read more … read more...

Daily Insider Ratings Round Up 11/6/18

via: SeekingAlpha at 2018-11-09 10:10:03:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10-dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

Apollo Endosurgery down 23% premarket after Q3 miss

via: SeekingAlpha at 2018-11-09 07:46:49:000

Thinly traded micro cap Apollo Endosurgery (NASDAQ: APEN ) is down 23% premarket on light volume following its Q3 report released after the close yesterday. Highlights: More news on: Apollo Endosurgery, ReShape Lifesciences Inc., Healthcare stocks news, Earnings news and comm… read more...

Apollo Endosurgery misses by $0.10, misses on revenue

via: SeekingAlpha at 2018-11-08 16:55:27:000

Apollo Endosurgery (NASDAQ: APEN ): Q3 GAAP EPS of -$0.45 misses by $0.10 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery, Inc. Reports Third Quarter 2018 Results

via: Business Wire at 2018-11-08 16:00:00:000

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the third quarter ended Sep… read more...

Apollo Endosurgery, Inc. to Report Third Quarter Results on November 8, 2018

via: Business Wire at 2018-11-06 16:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2018 on Th… read more...

Apollo Endosurgery, Inc. to Report Third Quarter Results on November 8, 2018

via: Business Wire at 2018-11-06 16:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2018 on Th… read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors

via: SeekingAlpha at 2018-10-09 08:51:46:000

Apollo Endosurgery (NASDAQ: APEN ) has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endoscopic Scissors in the U.S., Europe, and select other markets. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

via: Business Wire at 2018-10-09 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor Flexible Endo… read more...

Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

via: Business Wire at 2018-10-01 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced completion of enrollment in the ORBERA Post Approval Study evaluating the ORBERA intragastric balloon. Th… read more...

Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

via: Business Wire at 2018-10-01 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced completion of enrollment in the ORBERA Post Approval Study evaluating the ORBERA intragastric balloon. Th… read more...

Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

via: Business Wire at 2018-10-01 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced completion of enrollment in the ORBERA Post Approval Study evaluating the ORBERA intragastric balloon. Th… read more...

Apollo Endosurgery and Istituto Clinico Humanitas in Milano, Italy Establish European Registry for Flexible Endoscopic Suturing Procedures in Gastrointestinal Applications

via: Business Wire at 2018-09-24 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today an agreement with Istitudo Clinico Humanitas to establish a multicenter, retrospective, data repository for gastroi… read more...

Apollo Endosurgery and Istituto Clinico Humanitas in Milano, Italy Establish European Registry for Flexible Endoscopic Suturing Procedures in Gastrointestinal Applications

via: Business Wire at 2018-09-24 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today an agreement with Istitudo Clinico Humanitas to establish a multicenter, retrospective, data repository for gastroi… read more...

Apollo Endosurgery and Istituto Clinico Humanitas in Milano, Italy Establish European Registry for Flexible Endoscopic Suturing Procedures in Gastrointestinal Applications

via: Business Wire at 2018-09-24 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today an agreement with Istitudo Clinico Humanitas to establish a multicenter, retrospective, data repository for gastroi… read more...

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-12 11:00:42:000

Apollo Endosurgery, Inc. (APEN) Q2 2018 Results Earnings Conference Call August 08, 2018 04:30 PM ET Executives Lee Roth - The Ruth Group Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Analysts Matt Hewitt - Craig-Hallum Capital Suraj… read more...

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-12 11:00:42:000

Apollo Endosurgery, Inc. (APEN) Q2 2018 Results Earnings Conference Call August 08, 2018 04:30 PM ET Executives Lee Roth - The Ruth Group Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Analysts Matt Hewitt - Craig-Hallum Capital Suraj… read more...

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-12 11:00:42:000

Apollo Endosurgery, Inc. (APEN) Q2 2018 Results Earnings Conference Call August 08, 2018 04:30 PM ET Executives Lee Roth - The Ruth Group Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Analysts Matt Hewitt - Craig-Hallum Capital Suraj… read more...

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-12 11:00:42:000

Apollo Endosurgery, Inc. (APEN) Q2 2018 Results Earnings Conference Call August 08, 2018 04:30 PM ET Executives Lee Roth - The Ruth Group Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Analysts Matt Hewitt - Craig-Hallum Capital Suraj… read more...

Apollo Endosurgery misses by $0.09, misses on revenue

via: SeekingAlpha at 2018-08-08 16:17:12:000

Apollo Endosurgery (NASDAQ: APEN ): Q2 EPS of -$0.53 misses by $0.09 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery misses by $0.09, misses on revenue

via: SeekingAlpha at 2018-08-08 16:17:12:000

Apollo Endosurgery (NASDAQ: APEN ): Q2 EPS of -$0.53 misses by $0.09 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery misses by $0.09, misses on revenue

via: SeekingAlpha at 2018-08-08 16:17:12:000

Apollo Endosurgery (NASDAQ: APEN ): Q2 EPS of -$0.53 misses by $0.09 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery misses by $0.09, misses on revenue

via: SeekingAlpha at 2018-08-08 16:17:12:000

Apollo Endosurgery (NASDAQ: APEN ): Q2 EPS of -$0.53 misses by $0.09 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

via: Business Wire at 2018-08-08 16:01:00:000

OverStitch Product Sales Increase 37% Year-Over-Year Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures,… read more...

Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

via: Business Wire at 2018-08-08 16:01:00:000

OverStitch Product Sales Increase 37% Year-Over-Year Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures,… read more...

Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

via: Business Wire at 2018-08-08 16:01:00:000

OverStitch Product Sales Increase 37% Year-Over-Year Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures,… read more...

Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

via: Business Wire at 2018-08-08 16:01:00:000

OverStitch Product Sales Increase 37% Year-Over-Year Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures,… read more...

Apollo Endosurgery, Inc. to Report Second Quarter Results on August 8, 2018

via: Business Wire at 2018-08-06 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Company is scheduled to release its financial results for the second quarter ended June 30, 2018 on Wednes… read more...

Apollo Endosurgery, Inc. to Report Second Quarter Results on August 8, 2018

via: Business Wire at 2018-08-06 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Company is scheduled to release its financial results for the second quarter ended June 30, 2018 on Wednes… read more...

Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-06-28 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has received Special 510(k) clearance from the U.S. Food and Drug Administration for OverStitch Sx … read more...

Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-06-28 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has received Special 510(k) clearance from the U.S. Food and Drug Administration for OverStitch Sx … read more...

Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-06-28 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has received Special 510(k) clearance from the U.S. Food and Drug Administration for OverStitch Sx … read more...

Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2018-06-28 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has received Special 510(k) clearance from the U.S. Food and Drug Administration for OverStitch Sx … read more...

Apollo Endosurgery Makes Good Progress

via: SeekingAlpha at 2018-06-26 05:15:59:000

There weren't many companies whose stocks ended in the green on a grim Monday (June 25) but the shares of Apollo Endosurgery ( APEN ), the producer of anti-obesity products did: The shares have also recovered very nicely from the December lows, although most of that happened quite rapidly at… read more...

Apollo Endosurgery Makes Good Progress

via: SeekingAlpha at 2018-06-26 05:15:59:000

There weren't many companies whose stocks ended in the green on a grim Monday (June 25) but the shares of Apollo Endosurgery ( APEN ), the producer of anti-obesity products did: The shares have also recovered very nicely from the December lows, although most of that happened quite rapidly at… read more...

Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter's Full Exercise of Over-Allotment Option

via: Business Wire at 2018-06-22 16:01:00:000

Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the closing of its previously announced underwritten public offering of 4,309,090 shares of its common stock, including 562,055 shares sold pursua… read more...

Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter's Full Exercise of Over-Allotment Option

via: Business Wire at 2018-06-22 16:01:00:000

Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the closing of its previously announced underwritten public offering of 4,309,090 shares of its common stock, including 562,055 shares sold pursua… read more...

Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter's Full Exercise of Over-Allotment Option

via: Business Wire at 2018-06-22 16:01:00:000

Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the closing of its previously announced underwritten public offering of 4,309,090 shares of its common stock, including 562,055 shares sold pursua… read more...

Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter's Full Exercise of Over-Allotment Option

via: Business Wire at 2018-06-22 16:01:00:000

Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the closing of its previously announced underwritten public offering of 4,309,090 shares of its common stock, including 562,055 shares sold pursua… read more...

Premarket Gainers as of 9:05 am (6/20/2018)

via: SeekingAlpha at 2018-06-20 09:28:55:000

NAKD +370% . More news on: Naked Brand Group, Inc., Caladrius Biosciences, Inc., Lightbridge Corp, Stocks on the move, Read more … read more...

Apollo Endosurgery prices $20.6M common stock offering

via: SeekingAlpha at 2018-06-20 07:43:11:000

Apollo Endosurgery (NASDAQ: APEN ) prices its public offering of 3,747,035 shares of common stock at a price of $5.50 per share for gross proceeds of ~$20.6M. More news on: Apollo Endosurgery, Healthcare stocks news, Read more … read more...

Apollo Endosurgery, Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock

via: Business Wire at 2018-06-20 07:00:00:000

Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the pricing of an underwritten public offering of 3,747,035 shares of its common stock at a public offering price of $5.50 per share for gross pro… read more...

Apollo Endosurgery, Inc. Announces Commencement of Public Offering of Common Stock

via: Business Wire at 2018-06-19 16:00:00:000

Apollo Endosurgery, Inc.(Apollo) (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwri… read more...

Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)

via: Business Wire at 2018-06-05 09:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced todays presentation of results from Mayo Clinics prospective open-label study of the ORBERA Intraga… read more...

Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)

via: Business Wire at 2018-06-05 09:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced todays presentation of results from Mayo Clinics prospective open-label study of the ORBERA Intraga… read more...

Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)

via: Business Wire at 2018-06-05 09:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced todays presentation of results from Mayo Clinics prospective open-label study of the ORBERA Intraga… read more...

Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)

via: Business Wire at 2018-06-05 09:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced todays presentation of results from Mayo Clinics prospective open-label study of the ORBERA Intraga… read more...

Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery

via: Business Wire at 2018-06-04 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced the presentation of the study results Mortality and Inpatient Costs of Revisional Bariatric Surgery: A Nationwide… read more...

Aspen Endosurgery down 11% on uptick in malfunction rate of intragastric balloon

via: SeekingAlpha at 2018-06-04 13:29:15:000

Thinly traded micro cap Apollo Endosurgery ( APEN -8.1% ) slips on more than double normal volume, albeit on turnover of only 43K shares, in apparent response to its announcement of labeling updates for intragastric balloon system ORBERA, used to control food intake (thereby promoting we… read more...

Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System

via: Business Wire at 2018-06-04 13:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq: APEN) a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that the United States Food and Drug Administration (FDA) has approved updates to the ORBERA Intragastric Bal… read more...

Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week® 2018 titled: "Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon"

via: Business Wire at 2018-06-04 08:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced Digestive Disease Week presentation of a meta analysis that concluded fluid-filled balloons, like the ORBERA Intrag… read more...

Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors

via: Business Wire at 2018-05-31 17:59:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN) today announced that Dr. Julie Shimer, who led Welch Allyn Inc. and Vocera Communications as its Chief Executive Officer and President, has been appointed to Apollos Board of Directors by shareholder election on May 23, … read more...

Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors

via: Business Wire at 2018-05-31 17:59:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN) today announced that Dr. Julie Shimer, who led Welch Allyn Inc. and Vocera Communications as its Chief Executive Officer and President, has been appointed to Apollos Board of Directors by shareholder election on May 23, … read more...

Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors

via: Business Wire at 2018-05-31 17:59:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN) today announced that Dr. Julie Shimer, who led Welch Allyn Inc. and Vocera Communications as its Chief Executive Officer and President, has been appointed to Apollos Board of Directors by shareholder election on May 23, … read more...

Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference

via: Business Wire at 2018-05-24 17:44:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today its participation during Digestive Disease Week 2018 (DDW). DDW will be held June 2-5, 2018 at the … read more...

Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference

via: Business Wire at 2018-05-24 17:44:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today its participation during Digestive Disease Week 2018 (DDW). DDW will be held June 2-5, 2018 at the … read more...

Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference

via: Business Wire at 2018-05-24 17:44:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today its participation during Digestive Disease Week 2018 (DDW). DDW will be held June 2-5, 2018 at the … read more...

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients

via: Business Wire at 2018-05-14 05:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy an… read more...

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients

via: Business Wire at 2018-05-14 05:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy an… read more...

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients

via: Business Wire at 2018-05-14 05:00:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy an… read more...

Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures

via: Business Wire at 2018-05-08 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (ESG&#… read more...

Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures

via: Business Wire at 2018-05-08 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (ESG&#… read more...

Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures

via: Business Wire at 2018-05-08 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (ESG&#… read more...

Apollo Endosurgery misses by $0.07, misses on revenue

via: SeekingAlpha at 2018-05-03 16:18:31:000

Apollo Endosurgery (NASDAQ: APEN ): Q1 EPS of -$0.47 misses by $0.07 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery misses by $0.07, misses on revenue

via: SeekingAlpha at 2018-05-03 16:18:31:000

Apollo Endosurgery (NASDAQ: APEN ): Q1 EPS of -$0.47 misses by $0.07 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery misses by $0.07, misses on revenue

via: SeekingAlpha at 2018-05-03 16:18:31:000

Apollo Endosurgery (NASDAQ: APEN ): Q1 EPS of -$0.47 misses by $0.07 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apollo Endosurgery, Inc. Reports First Quarter 2018 Results

via: Business Wire at 2018-05-03 16:01:00:000

Total Endo-bariatric Product Sales Increased 40% in the First Quarter Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal proce… read more...

Apollo Endosurgery, Inc. Reports First Quarter 2018 Results

via: Business Wire at 2018-05-03 16:01:00:000

Total Endo-bariatric Product Sales Increased 40% in the First Quarter Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal proce… read more...

Apollo Endosurgery, Inc. Reports First Quarter 2018 Results

via: Business Wire at 2018-05-03 16:01:00:000

Total Endo-bariatric Product Sales Increased 40% in the First Quarter Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal proce… read more...

Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018

via: Business Wire at 2018-04-26 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018,… read more...

Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018

via: Business Wire at 2018-04-26 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018,… read more...

Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018

via: Business Wire at 2018-04-26 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018,… read more...

Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365(TM) - in the Kingdom of Saudi Arabia

via: Business Wire at 2018-04-23 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365 Managed Weight Loss System and has… read more...

Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365(TM) - in the Kingdom of Saudi Arabia

via: Business Wire at 2018-04-23 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365 Managed Weight Loss System and has… read more...

Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365(TM) - in the Kingdom of Saudi Arabia

via: Business Wire at 2018-04-23 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365 Managed Weight Loss System and has… read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-13 08:06:51:000

Celgene (NASDAQ: CELG ) resumed with Equal Weight rating and $93 (4% upside) price target at Morgan Stanley. More news on: Celgene Corporation, Corcept Therapeutics Incorporated, Endocyte, Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-13 08:06:51:000

Celgene (NASDAQ: CELG ) resumed with Equal Weight rating and $93 (4% upside) price target at Morgan Stanley. More news on: Celgene Corporation, Corcept Therapeutics Incorporated, Endocyte, Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-13 08:06:51:000

Celgene (NASDAQ: CELG ) resumed with Equal Weight rating and $93 (4% upside) price target at Morgan Stanley. More news on: Celgene Corporation, Corcept Therapeutics Incorporated, Endocyte, Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...

Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study

via: Business Wire at 2018-03-12 18:10:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND Lower Body Mass Index (BMI) Post-approval study (&#… read more...

Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study

via: Business Wire at 2018-03-12 18:10:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND Lower Body Mass Index (BMI) Post-approval study (&#… read more...

Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study

via: Business Wire at 2018-03-12 18:10:00:000

Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND Lower Body Mass Index (BMI) Post-approval study (&#… read more...

Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

via: Business Wire at 2018-03-05 16:05:00:000

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30 th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton La… read more...

Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

via: Business Wire at 2018-03-05 16:05:00:000

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30 th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton La… read more...

Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

via: Business Wire at 2018-03-05 16:05:00:000

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30 th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton La… read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-01 20:28:10:000

Apollo Endosurgery (APEN) Q4 2017 Earnings Conference Call March 01, 2018 04:30 PM ET Executives Lee Roth - SVP, The Ruth Group, IR Todd Newton - CEO Stefanie Cavanaugh - CFO Analysts Charlie Eidson - Craig-Hallum Capital Group David Solomon - ROTH Capital Partners. Su… read more...

Apollo Endosurgery's (APEN) CEO Todd Newton on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-01 20:28:10:000

Apollo Endosurgery (APEN) Q4 2017 Earnings Conference Call March 01, 2018 04:30 PM ET Executives Lee Roth - SVP, The Ruth Group, IR Todd Newton - CEO Stefanie Cavanaugh - CFO Analysts Charlie Eidson - Craig-Hallum Capital Group David Solomon - ROTH Capital Partners. Su… read more...

Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering

via: SeekingAlpha at 2018-01-05 01:36:56:000

Analysis of top Seeking Alpha coverage: ChemoCentryx Today we will discuss an update from ChemoCentryx ( CCXI ), which sent shares more than 30% higher in intra-day trading. ChemoCentryx is primarily focused on orphan and rare diseases. The companys lead product candidate is Avac… read more...

Your Daily Pharma Scoop: Intercept Updates On NASH Trial, GW Pharmaceuticals Provides Regulatory Update, Odonate Initiates Trial

via: SeekingAlpha at 2017-12-30 13:35:25:000

Analysis of top Seeking Alpha coverage: Intercept Today we will discuss an update from Intercept Pharmaceuticals ( ICPT ) with regards to its REVERSE trial in NASH patients with compensated cirrhosis. Intercept had earlier guided for commencing the Phase 3 trial by the end of this year… read more...

Your Daily Pharma Scoop: Amgen Plans To Bring Back Cash, Roche Acquires Ignyta, Agile Tumbles On CRL

via: SeekingAlpha at 2017-12-26 04:23:59:000

Analysis of top Seeking Alpha coverage: Amgen Today we will discuss Amgens ( AMGN ) plans to repatriate some of its cash holdings outside the U.S. In a SEC filing, Amgen noted that it expects to incur $6-$6.5 billion in tax expenses over time as it brings the cash back into the U… read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-12-19 17:35:38:000

Top gainers: MU +5.1% . TA +2.5% . IONS +2.1% . ITCB +1.5% . FDX +1.4% . More news on: Micron Technology Inc., TravelCenters of America LLC, Ionis Pharmaceuticals, Inc., Stocks on the move, Read more … read more...

Your Daily Pharma Scoop: Acadia Valuation, Galectin Plunges, Revance Positive Result

via: SeekingAlpha at 2017-12-06 04:24:34:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-11-28 12:44:34:000

Gainers: APEN +53% . CREG +33% . OHGI +20% . OTCPK:OMNT +21% . COOL +16% . TEUM +14% . SMIT +14% . THO +13% . QNST +12% . OTCQB:MRDN +11% . More news on: Apollo Endosurgery, China Recycling Energy Corporation, One Horizon Group, Inc., Stocks on t… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2017-11-28 09:23:53:000

APEN +35% as FDA clears Apollo's new endoscopic suturing system. More news on: Apollo Endosurgery, Pareteum Corporation, Christopher & Banks Corporation, Stocks on the move, Read more … read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-11-27 17:36:10:000

Top gainers: APEN +26.5% . THO +10.4% . SRRA +9.4% . WGO +5.1% . TECD +4.6% . More news on: Apollo Endosurgery, Thor Industries, Inc., Sierra Oncology, Inc., Stocks on the move, Read more … read more...

Apollo Endosurgery Receives FDA Clearance for OverStitch(TM) Sx Endoscopic Suturing System

via: Business Wire at 2017-11-27 16:01:00:000

Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S. Food and Drug Administration 510k clearance of the OverStitch Sx, a new, full-thickness flexible endoscopic … read more...

Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference

via: Business Wire at 2017-11-17 16:01:00:000

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 29 th Annual Piper Jaffray Healthcare Conference on November 28, 2017 at 8:50 am… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-12-30 5.5 1.0 5.5
2016-06-13 14.0 1.0 14.0
Data provided for free by IEX